LUMEFANTRINE
Semler gets WHO notice of concern over violation of ideal laboratory and clinical practicesThe WHO said its findings bring into question the validity of studies (performed for 12 products) that are under assessment, but not prequa...
Nutraplus starts production of Lumefantrine at Tarapur plantPharma firm Nutraplus India has started commercial production of anti-malarial drug Lumefantrine at its new plant at Tarapur in Maharashtra.
New drug combo therapy may treat malaria in children'Artemisinin-naphthoquine drug-combo should be considered for the treatment of uncomplicated malaria in settings where multiple parasite sp...
Strides gets WHO pre-qualification for anti-malarial tabletsDrug firm Strides Arcolab today said it has received World Health Organisation (WHO) pre- qualification for its anti-malarial tablets.- Arihant recommends 'Accumulate' on Ipca LaboratoriesArihant Capital Services has recommended to ‘Accumulate’ Ipca Laboratories even as the company’s fourth quarter results were “marginally be...
Load More